Yada Kanjanapan

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 8

Top Venues

The Medical journal of Australia

Cancer

JNCI cancer spectrum

Internal medicine journal

This page only lists publications with an associated author ORCID identifier.

Publications

Yada Kanjanapan, Geetha Guduguntla, Ashwati Krishnan Varikara, Jeremy Szajer, Desmond Yip, John Cockburn, Mitali Fadia
Hyperprogressive Disease (HPD) in Solid Tumours Receiving Immune Checkpoint Inhibitors in a Real-World Setting. Technology in cancer research & treatment 22 (2023)
Yada Kanjanapan, Prunella Blinman, Underhill Craig, Deme J Karikios, Eva Segelov, Desmond Yip
Medical Oncology Group of Australia position statement: COVID-19 vaccination in patients with solid tumours. Internal medicine journal 51 (6) (2021)
Yada Kanjanapan, Daniel Gilbourd, Ganesalingam Pranavan
Acute ischaemic stroke following cisplatin-based chemotherapy for testicular cancer. BMJ case reports 13 (5) (2020)
Yada Kanjanapan, Desmond Yip
Characteristics and risk factors for microbial infections during cancer immune checkpoint therapy. Cancer medicine 9 (23) (2020)
Yada Kanjanapan, Sheau Wen Lok, Peter Gibbs, Richard De Boer, Belinda Yeo, Sally Greenberg, Frances Barnett, Louise Knott, Gary Richardson, Rachel Wong, Michelle Nottage, Ian M Collins, Javier Torres, Janine Lombard, Julie Johns, Michael Harold, Laeeq Malik
Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer. Breast cancer research and treatment 184 (1) (2020)
Yada Kanjanapan, Desmond Yip
Considerations for cancer immunotherapy during the COVID-19 pandemic. The Medical journal of Australia 213 (9) (2020)
Yada Kanjanapan, Daphne Day, Lisa Wang, Hamad Al-Sawaihey, Engy Abbas, Amirali Namini, Lillian L Siu, Aaron Hansen, Albiruni Abdul Razak, Anna Spreafico, Natasha Leighl, Anthony M Joshua, Marcus O Butler, David Hogg, Mary Anne Chappell, Ludmilla Soultani, Kayla Chow, Samantha Boujos, Philippe L Bedard
Hyperprogressive disease in early-phase immunotherapy trials: Clinical predictors and association with immune-related toxicities. Cancer 125 (8) (2019)
Aaron R Hansen, Christina Guo, Yada Kanjanapan, Ben Tran, Anna Spreafico, Anthony M Joshua, Lisa Wang, Albiruni R Abdul Razak, Natasha B Leighl, Aaron R Hansen, Marcus O Butler, Lillian L Siu, Jayesh Desai, Philippe L Bedard
Survival in Early Phase Immuno-Oncology Trials: Development and Validation of a Prognostic Index. JNCI cancer spectrum 3 (4) (2019)

Yada Kanjanapan.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yada Kanjanapan